Mark Zimmerman - Publications
Affiliations: | 2008-2013 | Pharmacology | University of Pittsburgh, Pittsburgh, PA, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2014 | Cramer JM, Zimmerman MW, Thompson T, Homanics GE, Lazo JS, Lagasse E. Deletion of Ptp4a3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice. Stem Cell Research. 13: 164-71. PMID 24950307 DOI: 10.1016/J.Scr.2014.05.004 | 0.476 | |||
2014 | Zimmerman MW, McQueeney KE, Isenberg JS, Pitt BR, Wasserloos KA, Homanics GE, Lazo JS. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility. The Journal of Biological Chemistry. 289: 5904-13. PMID 24403062 DOI: 10.1074/Jbc.M113.480038 | 0.447 | |||
2013 | Zimmerman MW, Homanics GE, Lazo JS. Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer. Plos One. 8: e58300. PMID 23555575 DOI: 10.1371/Journal.Pone.0058300 | 0.484 | |||
2012 | Zimmerman M, Homanics G, Lazo J. 47 Targeting Ptp4a3 in Colon Tumorigenesis and Cancer Progression European Journal of Cancer. 48: 16. DOI: 10.1016/S0959-8049(12)71845-2 | 0.427 | |||
Show low-probability matches. |